Lon­za swoops in with $1.2B to take over Roche’s bi­o­log­ics site in Cal­i­for­nia

Last year
Manufacturing

Non­prof­it tracks surge in med­ica­tion abor­tions as SCO­TUS gears up for hear­ing

Last year
Pharma
Law

Sen­a­tors press De­part­ment of De­fense on over­re­liance on for­eign drug man­u­fac­tur­ers

Last year
Pharma
FDA+

Phar­ma com­pa­nies ques­tion new EU in­cen­tives as re­vamp ad­vances

Last year
Pharma
Law

No­vo Nordisk bol­sters op­er­a­tions in Chi­na with $556M ex­pan­sion project

Last year
China
Pharma

FDA pro­pos­es tight­en­ing re­stric­tions on com­pound­ing three cat­e­gories of drugs

Last year
Pharma
FDA+

Takeda's $5.2B Ari­ad deal pays off with a la­bel ex­pan­sion in rare form of leukemia

Last year
Pharma

No­var­tis’ CD­MO arm eyes growth, scope to wel­come com­peti­tors’ clients 

Last year
Manufacturing

In Oprah’s TV spe­cial, We­govy and Zep­bound are the stars

Last year
Pharma
Marketing

Mar­ket­ingRx roundup: Bris­tol My­ers en­lists Ted Dan­son for pso­ri­a­sis cam­paign; Re­gen­eron de­buts Eylea HD ef­fort

Last year
Pharma
Marketing

As­traZeneca views $2B+ Fu­sion buy­out as ‘start­ing point’ for bet­ter ra­dio­phar­ma­ceu­ti­cals, com­bos

Last year
Deals
Pharma

‘An AI foundry’: Nvidia’s Jensen Huang pitch­es biotech on easy AI, with fo­cus on soft­ware go­ing be­yond chips

Last year
AI

Madri­gal's $600M of­fer­ing; PureTech to re­turn $100M to share­hold­ers

Last year
News Briefing

High­ly-await­ed PhI­II study of Gates-backed tu­ber­cu­lo­sis vac­cine un­der­way

Last year
R&D

Mor­gan Health, JP Mor­gan’s health­care ven­ture, is look­ing to cut phar­ma costs next

Last year
Health Tech

Mid-stage neu­ro­science start­up En­grail rais­es $157M

Last year
Financing
Startups

Cri­net­ics re­ports sec­ond PhI­II win for acromegaly drug, eyes 2025 launch

Last year
R&D

With pos­i­tive PhI­II da­ta in hot flash­es, Bay­er is a step clos­er to chal­leng­ing Astel­las’ Veozah

Last year
R&D

As­traZeneca snaps up ra­dio­phar­ma part­ner for $2B up­front

Last year
Deals

No­vo Nordisk Foun­da­tion backs ef­fort to build su­per­com­put­er with Nvidia

Last year
R&D
AI

Study sug­gests con­tro­ver­sial patent re­view path­way is ef­fec­tive for bi­o­log­ics

Last year
Pharma

Up­dat­ed: FDA ex­pands la­bel for nasal spray to treat chron­ic si­nus in­flam­ma­tion

Last year
Pharma
FDA+

Ap­peals court re­vers­es No­var­tis win over Re­gen­eron in Eylea-Lu­cen­tis bat­tle

Last year
Pharma
Law

FDA green­lights Or­chard's gene ther­a­py Len­meldy for rare and fa­tal dis­ease

Last year
Pharma
Cell/Gene Tx
First page Previous page 183184185186187188189 Next page Last page
A service from the Financial Times